COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,913 Articles (22,044 medRxiv, 7,869 bioRxiv)

Most recent first Previous |  Page 2862: Articles 28611-28620  | Next

Explaining the Bomb-Like Dynamics of COVID-19 with Modeling and the Implications for Policy
Lin, G., Strauss, A. T., Pinz, M., Martinez, D. A., Tseng, K. K., Schueller, E., Gatalo, O., Yang, Y., Levin, S. A., Klein, E. Y., For the CDC MInD-Healthcare Program
10.1101/2020.04.05.20054338 — Posted: 2020-04-07
Longitudinal analysis of laboratory findings during the process of recovery for patients with COVID-19
Tian, S., Zhu, X., Sun, X., Wang, J., Zhou, Q., Wang, C., Chen, L., Xu, J.
10.1101/2020.04.04.20053280 — Posted: 2020-04-07
Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-Co2 virus detection
Gonzalez-Gonzalez, E., Trujillo-de Santiago, G., Lara-Mayorga, I. M., Martinez-Chapa, S. O., Alvarez, M. M.
10.1101/2020.04.03.20052860 — Posted: 2020-04-07
Indoor transmission of SARS-CoV-2
Qian, H., Miao, T., LIU, L., Zheng, X., Luo, D., Li, Y.
10.1101/2020.04.04.20053058 — Posted: 2020-04-07 Discussion: Onsite
Investigating the likely association between genetic ancestry and COVID-19 manifestation
Das, R., Ghate, S. D.
10.1101/2020.04.05.20054627 — Posted: 2020-04-07 Discussion: Onsite
Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking
Mahapatra, S., Nath, P., Chatterjee, M., Das, N., Kalita, D., Roy, P., Satapathi, S.
10.1101/2020.04.05.20054254 — Posted: 2020-04-07 Discussion: Onsite
An "Infodemic": Leveraging High-Volume Twitter Data to Understand Public Sentiment for the COVID-19 Outbreak
Medford, R. J., Saleh, S. N., Sumarsono, A., Perl, T. M., Lehmann, C. U.
10.1101/2020.04.03.20052936 — Posted: 2020-04-07
Thoughts on Higher Medical Education Under Major Public Health Emergencies: Thinking Ahead After COVID-19 Outbreak
Lin, W., Chen, Y., Shi, S., Liang, J., Huang, H., Li, L., Cai, L., Zong, L., Wang, N., Wen, J., Chen, G.
10.1101/2020.04.06.20053918 — Posted: 2020-04-07
Increased Detection coupled with Social Distancing and Health Capacity Planning Reduce the Burden of COVID-19 Cases and Fatalities: A Proof of Concept Study using a Stochastic Computational Simulation Model
Ghosh, P., Basheer, S., Paul, S., Chakrabarti, P., Sarkar, J.
10.1101/2020.04.05.20054775 — Posted: 2020-04-07
Mandated Bacillus Calmette-Guerin (BCG) vaccination predicts flattened curves for the spread of COVID-19
Berg, M. K., Yu, Q., Salvador, C. E., Melani, I., Kitayama, S.
10.1101/2020.04.05.20054163 — Posted: 2020-04-07 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).